- Home
- ALNY vs FDX Comparison
ALNY vs FDX Comparison
Compare ALNY & FDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALNY
- FDX
- Stock Information
- Founded
- ALNY 2002
- FDX 1971
- Country
- ALNY United States
- FDX United States
- Employees
- ALNY N/A
- FDX N/A
- Industry
- ALNY Biotechnology: Pharmaceutical Preparations
- FDX Air Freight/Delivery Services
- Sector
- ALNY Health Care
- FDX Consumer Discretionary
- Exchange
- ALNY Nasdaq
- FDX Nasdaq
- Market Cap
- ALNY 59.6B
- FDX 53.6B
- IPO Year
- ALNY 2004
- FDX N/A
- Fundamental
- Price
- ALNY $455.91
- FDX $240.44
- Analyst Decision
- ALNY Strong Buy
- FDX Buy
- Analyst Count
- ALNY 29
- FDX 17
- Target Price
- ALNY $448.97
- FDX $271.82
- AVG Volume (30 Days)
- ALNY 1.0M
- FDX 2.5M
- Earning Date
- ALNY 10-30-2025
- FDX 09-18-2025
- Dividend Yield
- ALNY N/A
- FDX 2.42%
- EPS Growth
- ALNY N/A
- FDX 5.51
- EPS
- ALNY N/A
- FDX 17.09
- Revenue
- ALNY $2,461,963,000.00
- FDX $88,591,000,000.00
- Revenue This Year
- ALNY $59.55
- FDX $5.01
- Revenue Next Year
- ALNY $40.90
- FDX $4.09
- P/E Ratio
- ALNY N/A
- FDX $14.04
- Revenue Growth
- ALNY 5.01
- FDX 1.14
- 52 Week Low
- ALNY $205.87
- FDX $194.30
- 52 Week High
- ALNY $484.21
- FDX $308.53
- Technical
- Relative Strength Index (RSI)
- ALNY 61.36
- FDX 54.19
- Support Level
- ALNY $448.95
- FDX $231.90
- Resistance Level
- ALNY $465.01
- FDX $250.09
- Average True Range (ATR)
- ALNY 10.66
- FDX 5.24
- MACD
- ALNY -1.55
- FDX 0.79
- Stochastic Oscillator
- ALNY 81.95
- FDX 51.35
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
About FDX FedEx Corporation
FedEx pioneered overnight delivery in 1973 and remains the world's largest express package provider. In fiscal 2025, the firm's Federal Express segment—which houses the core package delivery operations—made up 86% of total revenue, with 10% coming from FedEx Freight, its asset-based less-than-truckload shipping segment. The remainder came from other services, including FedEx Office, which provides document production/shipping, and FedEx Logistics, which provides global forwarding. FedEx acquired Dutch parcel delivery firm TNT Express in 2016, boosting its presence across Europe. TNT was previously the fourth-largest global parcel delivery provider.